Search - tctmd.com

Displaying 381 - 400 of 408

Sort: Relevancy | Date

News Industry News

CardiAQ Offers New Hope For Cardiovascular Medicine

June 19, 2012

News Industry News

CardiAQ™ Valve Technologies Reports Cardiovascular Medicine Milestone: First-in-Human Nonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve

June 14, 2012

Presentation TVT 2012

Recurrent Mitral Regurgitation (MR) After MV Repair: Incidence and Mechanisms

Presenter: Ted Feldman

June 05, 2012

Presentation TVT 2012

Case Study 2: Recurrent MR After Surgical Repair for Functional MR

Presenter: David Adams

June 05, 2012

Presentation TVT 2012

Case Study 1: Recurrent MR After Surgical Repair for Degenerative MR

Presenter: Allan Schwartz

June 05, 2012

News Daily News

La Ecografía Mejorada con Contraste es una Alternativa Viable a la ACTC en el Seguimiento de una EVAR

May 24, 2012

News Daily News

Contrast-Enhanced Ultrasound Viable Alternative to CTA for EVAR Follow-up

May 24, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Daily News

Mitral Repair Can Augment Heart Function in CABG Patients

Caitlin E. Cox

March 04, 2012

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

News Daily News

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Caitlin E. Cox

January 17, 2012

News Daily News

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Jason Kahn

January 04, 2012

News Industry News

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 03, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Conference News

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

April 04, 2011

News Industry News

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

April 04, 2011

News Industry News

Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011

March 28, 2011

Advertisement

CardiAQ Offers New Hope For Cardiovascular Medicine

CardiAQ™ Valve Technologies Reports Cardiovascular Medicine Milestone: First-in-Human Nonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve

Recurrent Mitral Regurgitation (MR) After MV Repair: Incidence and Mechanisms

Case Study 2: Recurrent MR After Surgical Repair for Functional MR

Case Study 1: Recurrent MR After Surgical Repair for Degenerative MR

La Ecografía Mejorada con Contraste es una Alternativa Viable a la ACTC en el Seguimiento de una EVAR

Contrast-Enhanced Ultrasound Viable Alternative to CTA for EVAR Follow-up

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

Experts Give Their Picks for Most Important Developments of 2011

Mitral Repair Can Augment Heart Function in CABG Patients

Novel Strategies Advance Cell Therapy for Cardiomyopathy

Expedited Cell Therapy After STEMI Shows Promise

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Abbott to Present New Data for Key Vascular Products at TCT 2011

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content